Form 4: GE HealthCare Executive Kevin O'Neill Reports Stock Transactions
SEC Form 4 Filing
Kevin O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reports the withholding of shares for tax obligations and the award of restricted stock units and employee stock options.
Summary
- On March 1, 2024, Kevin O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reported transactions involving GE HealthCare common stock.
- These transactions included the withholding of shares to cover tax obligations related to vesting restricted stock units and performance stock units.
- O'Neill also received an award of 3,235 restricted stock units, which will vest in three tranches on September 1, 2025, September 1, 2026, and September 1, 2027.
- Additionally, O'Neill was granted an employee stock option for 9,202 shares, also vesting in three tranches on the same dates as the restricted stock units.
- Following these transactions, O'Neill directly owns 24,010 shares of common stock and indirectly owns 59 shares through a share incentive plan trust.
- He also holds options for 9,202 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are routine and reflect standard executive compensation practices. The vesting schedule suggests a focus on long-term performance.
Positives
- The award of restricted stock units and employee stock options to a key executive like Kevin O'Neill can be seen as a positive sign, aligning his interests with the long-term performance of the company.
Future Outlook
The restricted stock units and employee stock options vest over a three-year period, suggesting a focus on long-term performance and retention of the executive.
Industry Context
Equity compensation is a common practice in the healthcare industry to incentivize executives and align their interests with shareholders. The vesting schedule is typical for such awards.
Comparison to Industry Standards
- Equity compensation packages for CEOs in the healthcare technology sector typically include a mix of restricted stock units and stock options.
- Vesting schedules of three to four years are standard to ensure long-term commitment.
- Companies like Siemens Healthineers and Philips also utilize similar equity-based compensation strategies for their top executives.
Stakeholder Impact
- The equity awards align the executive's interests with those of shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the reported transactions (withholding of shares, award of restricted stock units and employee stock options). |
| 03/05/2024 | Date of signature for the Form 4 filing. |
| 09/01/2025 | First vesting date (33%) for the restricted stock units and employee stock options. |
| 09/01/2026 | Second vesting date (33%) for the restricted stock units and employee stock options. |
| 09/01/2027 | Final vesting date (34%) for the restricted stock units and employee stock options. |
| 03/01/2034 | Expiration date for the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.